BMY vs LLY
Bristol Myers Squibb (BMY) and Lilly (Eli) (LLY) compared side by side. Lilly (Eli) (LLY) is larger, with a market cap of $1.1T versus $125.6B for Bristol Myers Squibb, about 9.0 times the size. On trailing earnings, BMY is cheaper at 13.5x versus 42.7x for LLY.
Head to head
| Metric | BMY | LLY |
|---|---|---|
| Market cap | $125.6B | $1.1T |
| P/E (TTM) | 13.5x | 42.7x |
| Forward P/E | 9.3x | 27.0x |
| Revenue (TTM) | $49.2B | $79.7B |
| Revenue growth | 5.7% | 47.7% |
| Gross margin | 71.7% | 83.4% |
| Operating margin | 34.4% | 54.2% |
| Free cash flow | $11.4B | $13.6B |
| Dividend yield | 4.10% | 0.54% |
| 1-year return | +46.5% | +56.1% |
| 5-year return (annual) | +5.6% | +40.5% |
| Max drawdown | -71% | -68% |
| FI Handbook grade | B | B |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
BMY vs LLY FAQ
Which is bigger, BMY or LLY?
Lilly (Eli) (LLY) is larger, with a market cap of $1.1T versus $125.6B for Bristol Myers Squibb, about 9.0 times the size.
Is BMY or LLY cheaper?
On trailing earnings, BMY is cheaper at 13.5x versus 42.7x for LLY. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, BMY or LLY?
LLY returned +56.1% over the past year including dividends, versus +46.5% for BMY, through October 23, 2026.
Which pays a higher dividend, BMY or LLY?
BMY yields 4.10% versus 0.54% for LLY.
Full pages: Bristol Myers Squibb · Lilly (Eli)